Newer brands, compounded drugs improve efficacy, compliance

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.
The use of compounded ophthalmic medications has long been a controversial topic. While the use of these products may give patients access to medications that they would not otherwise have, whether it is due to availability or affordability, they also come with certain risks.
This month, Gary Wörtz, MD, and Inder Paul Singh, MD, discuss their thoughts on the concept (Read more...)

Full Story →